For Q3 FY2025, consolidated net sales were JPY 72,503 million (YoY -0.5%), operating income was JPY 5,716 million (YoY -24.2%), and net income was JPY 5,949 million (YoY +2.0%).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4526","jir_company_name":"Riken Vitamin Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4526-20260212-03.pdf","jir_short_summary":"For Q3 FY2025, consolidated net sales were JPY 72,503 million (YoY -0.5%), operating income was JPY 5,716 million (YoY -24.2%), and net income was JPY 5,949 million (YoY +2.0%).","jir_summary":"### Overview of Consolidated Results\nConsolidated net sales for Q3 FY2025 amounted to JPY 72,503 million, a 0.5% decrease YoY. The domestic business recorded sales growth; however, a significant decline in overseas operations impacted results. Operating income was JPY 5,716 million, down 24.2% YoY, with the overseas segment posting an operating loss due to decreased sales and increased personnel expenses. Although operating income declined by JPY 678 million due to revised estimates of asset retirement obligations related to asbestos removal costs, the recognition of JPY 2,065 million in gain on sales from a reduction in policy-held stocks contributed to net income exceeding the prior year.\n\n### Segment Performance and Revision of Earnings Guidance\nThe domestic food business achieved net sales of JPY 50,352 million (+1.7% YoY), recording higher sales, though operating income declined to JPY 5,082 million (-10.2% YoY). Household food sales decreased, while sales of commercial-use food and processed food raw materials increased. The domestic chemical and other businesses posted net sales of JPY 6,477 million (+7.9% YoY) with slightly decreased operating income of JPY 675 million (-2.5% YoY). Overseas operations recorded net sales of JPY 16,961 million (-7.7% YoY) and an operating loss of JPY 97 million. The full-year FY2025 earnings forecast has been revised downward to net sales of JPY 96,000 million (-4.0% from previous forecast), operating income of JPY 6,200 million (-27.1%), and net income of JPY 6,500 million (-20.7%).","jir_financial_highlights":"Net Sales: JPY 72,503 million (YoY -0.5%)\nOperating Income: JPY 5,716 million (YoY -24.2%)\nOrdinary Income: JPY 6,403 million (YoY -22.3%)\nNet Income Attributable to Owners of Parent: JPY 5,949 million (YoY +2.0%)","jir_category":"","jir_hashtags":"#RikenVitaminCoLtd, #financial_summary, #JapaneseStocks","jir_key_figures":"Consolidated Net Sales: JPY 72,503 million (YoY -0.5%)\nConsolidated Operating Income: JPY 5,716 million (YoY -24.2%)\nNet Income Attributable to Owners of Parent: JPY 5,949 million (YoY +2.0%)","jir_meta_title":"Riken Vitamin Q3 FY2025 Supplementary Financial Results: Net Sales JPY 72,503 million, Operating Income JPY 5,716 million","jir_meta_description":"Supplementary materials for Riken Vitamin Co., Ltd.'s Q3 FY2025 financial results. Consolidated net sales were JPY 72,503 million (YoY -0.5%), operating income JPY 5,716 million (YoY -24.2%), and net income JPY 5,949 million (YoY +2.0%). Sales decline in overseas business and revision of asset retirement obligation estimates had an impact.","jir_og_title":"Riken Vitamin Q3 FY2025 Supplementary Financial Results","jir_og_description":"Riken Vitamin Q3 FY2025 supplementary financial results. Net sales of JPY 72,503 million, operating income of JPY 5,716 million, and net income of JPY 5,949 million. Challenges remain with decline in overseas sales.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Consolidated Net Sales Trend (FY2015 to FY2025 Forecast)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2015\\\",\\\"FY2016\\\",\\\"FY2017\\\",\\\"FY2018\\\",\\\"FY2019\\\",\\\"FY2020\\\",\\\"FY2021\\\",\\\"FY2022\\\",\\\"FY2023\\\",\\\"FY2024\\\",\\\"FY2025 Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales (JPY Million)\\\",\\\"data\\\":[88072,87181,89515,89024,82974,77722,79231,88750,91484,95582,96000],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Consolidated Operating Income Trend (FY2015 to FY2025 Forecast)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2015\\\",\\\"FY2016\\\",\\\"FY2017\\\",\\\"FY2018\\\",\\\"FY2019\\\",\\\"FY2020\\\",\\\"FY2021\\\",\\\"FY2022\\\",\\\"FY2023\\\",\\\"FY2024\\\",\\\"FY2025 Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income (JPY Million)\\\",\\\"data\\\":[6007,6820,5424,4580,5307,1367,5840,7158,9371,8724,6200],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Net Sales for Q3 FY2025\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Domestic Food Business\\\",\\\"Domestic Chemicals and Other Business\\\",\\\"Overseas Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales (JPY Million)\\\",\\\"data\\\":[50352,6477,16961],\\\"backgroundColor\\\":[\\\"#3cba9f\\\",\\\"#e8c3b9\\\",\\\"#c45850\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_operating_profit_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Income for Q3 FY2025\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Domestic Food Business\\\",\\\"Domestic Chemicals and Other Business\\\",\\\"Overseas Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income (JPY Million)\\\",\\\"data\\\":[5082,675,-97],\\\"backgroundColor\\\":[\\\"#3cba9f\\\",\\\"#e8c3b9\\\",\\\"#c45850\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"FY2025 Full-Year Earnings Forecast: Previous vs. Revised\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Net Sales\\\",\\\"Operating Income\\\",\\\"Ordinary Income\\\",\\\"Net Income Attributable to Owners of Parent\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Previous Forecast (JPY Million)\\\",\\\"data\\\":[100000,8500,9000,8200],\\\"backgroundColor\\\":\\\"#3e95cd\\\"},{\\\"label\\\":\\\"Revised Forecast (JPY Million)\\\",\\\"data\\\":[96000,6200,7000,6500],\\\"backgroundColor\\\":\\\"#8e5ea2\\\"}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":16690,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-28535","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n